Evelo Biosciences, Inc. Gains 39.83%
Mon, Jul 10, 2023 at 07:46 PM
Evelo Biosciences, Inc. (EVLO:NASDAQ) jumped higher at $3.23, a gain of 39.8%. The stock got featured on our News Catalysts scanner on Mon, Jul 10, 2023 at 10:22 AM in the 'PRIVATE PLACEMENT' category. From Mon, Jun 26, 2023, the stock recorded 22.22% Up Days and 40.00% Green Days
The stock spiked on Wed, Jun 28, 2023 at $5.54 with a volume of 1M+.
About Evelo Biosciences, Inc. (EVLO:NASDAQ)
Evelo Biosciences Inc operates as a bio-technology company. The firm develops therapies for the treatment of the gut-body network. Evelo Biosciences also offers treatment for cancer and inflammatory diseases.
Top 10 Gainers:
- Mobilicom Limited (MOB:NASDAQ), 88%
- Jupiter Wellness Inc. (JUPW:NASDAQ), 50.27%
- Viveve Medical, Inc. (VIVE:NASDAQ), 50%
- Laird Superfood Inc. (LSF:NYSEMKT), 43.9%
- Evelo Biosciences, Inc. (EVLO:NASDAQ), 39.83%
- T2 Biosystems, Inc. (TTOO:NASDAQ), 37.39%
- Prestige Wealth Inc. (PWM:NASDAQ), 32.01%
- Novavax, Inc. (NVAX:NASDAQ), 29.46%
- Stronghold Digital Mining Inc. (SDIG:NASDAQ), 28.59%
- Nanobiotix S.A. (NBTX:NASDAQ), 28.23%